Etienne P. Hoffer

CHU Namur
Yvoir, WAL, BE 
CHU Namur
Yvoir, WAL, BE 

Overview

Etienne Hoffer practices practicing medicine in Yvoir, Belgium.

His clinical expertise encompasses Endomyocardial Fibrosis, Coarctation of the Aorta, Ebstein's Anomaly, and Cardiogenic Shock.

He is actively involved in clinical research, co-authoring 17 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

CHU Namur
Yvoir, WAL, Belgium
Other Locations
CHR Citadelle
Liege, WAL, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia. NODE 301 and RAPID Studies
Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia. NODE 301 and RAPID Studies
Enrollment Status: Terminated
Publish Date: July 12, 2024
Intervention Type: Drug
Study Drug: Etripamil
Study Phase: Phase 3
Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry
Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry
Enrollment Status: Completed
Publish Date: July 19, 2022
View 1 Less Clinical Trial

17 Total Publications

Contemporary management of patients with atrial fibrillation in the Netherlands and Belgium: a report from the EORP-AF long-term general registry.
Contemporary management of patients with atrial fibrillation in the Netherlands and Belgium: a report from the EORP-AF long-term general registry.
Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
Published: August 10, 2021

Frequently Asked Questions about Etienne P. Hoffer

Is Etienne P. Hoffer a top-rated expert for Endomyocardial Fibrosis?

MediFind is an objective health platform that identifies experts based on real-world data. Etienne P. Hoffer is classified as an Experienced expert for Endomyocardial Fibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Etienne P. Hoffer participate in research or clinical trials?

Yes. Etienne P. Hoffer has published 17 articles and abstracts on conditions like Endomyocardial Fibrosis. You can view a list of Etienne P. Hoffer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hoffer's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile